Dr. Bart Alan Frizzell, MD

Dr. Frizzell practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.

Dr. Frizzell's NPI, 1528040581, was assigned on November 16, 2005. Dr. Frizzell graduated from University of Tennessee, Hsc, College of Medicine in 1996. Dr. Frizzell holds North Carolina license 200101042.

Dr. Frizzell's primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.

Dr. Frizzell's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dr. Frizzell is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Wake Forest Baptist. Dmand AI also links Dr. Frizzell to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Frizzell practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Frizzell's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Frizzell is licensed in North Carolina.

CMS data shows 1,001 Medicare services from Dr. Frizzell across 12 procedure codes in 2024, for 246 Medicare patients. Medicare paid $55,091 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 246 Medicare patients who saw Dr. Frizzell in 2024. The largest group is 65 to 74, with 140 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Frizzell's median patient age at 73, with 27% women.

In 2024, Dr. Frizzell wrote 82 Medicare Part D claims for 37 patients. 91% of them were for generic drugs. CMS names the drug for 44 of them, across 1 drug with 11 or more claims each, at $334 in total drug cost. In 2023, CMS named 49 claims across 1 drug.

Dr. Frizzell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 26 papers to Dr. Frizzell, published from 2012 to 2024. 2021 was the busiest year, with 5. The most frequent topics are Head and Neck Neoplasms, Prostatic Neoplasms and Carcinoma, Squamous Cell. Dr. Frizzell has published most often in Cureus. Dr. Frizzell's most frequent co-authors are Ryan Thomas Hughes, Mercedes Porosnicu, MD and Thomas William Lycan, DO.

Dmand AI links Dr. Frizzell to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms, Squamous Cell Carcinoma of Head and Neck and Carcinoma, Squamous Cell. Wake Forest University Health Sciences sponsors the most, 2.

CMS Open Payments shows 1 general payment to Dr. Frizzell from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. TOLMAR Pharmaceuticals, Inc. paid the most, $111.

Dr. Frizzell graduated from University of Tennessee, Hsc, College of Medicine in 1996.